Loading patent…
AssigneeAhammune Biosciences Private Limited
InventorsParul GANJU, Sudhanand PRASAD, Mahesh Kumar VERMA, Kashinath KOMIRISHETTY, Annie RICHHARIA
Estimating the term…
The present invention relates to a process for preparing N-[2-[2-(4-chlorophenyl)-4-thiazolyl] ethyl]-butanamide. The present invention further relates to a pharmaceutical formulation and the use of said pharmaceutical formulation consisting of N-[2-[2-(4-chlorophenyl) -4-thiazolyl]ethyl]-butanamide or pharmaceutically acceptable salts thereof as active compound for the treatment and prevention of autoimmune diseases and diseases involving skin immunology, skin autoimmune diseases and pigmentation disorders.
A process for preparing N-[2-[2-(4-Chlorophenyl)-4-thiazolyl]ethyl]-butanamide, comprising the steps of:
A pharmaceutical formulation comprising N-[2-[2-(4-chlorophenyl)-4-thiazolyl]ethyl]-butanamide or pharmaceutically acceptable salts thereof as the active compound and a pharmaceutically acceptable excipient, wherein the strength of the active compound is in the range of 0.1% to 90%.
A method for the treatment of autoimmune diseases in a mammal diagnosed with the disease, the method comprising the step of administering to the mammal a therapeutically effective amount of N-[2-[2-(4-chlorophenyl)-4-thiazolyl]ethyl]-butanamide or pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.